Description

6-Cyclopropyl-1-Ethyl-1H-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid CAS NO 954261-91-7 is a high-purity heterocyclic carboxylic acid derivative, serving as a critical advanced pharmaceutical intermediate (API) and a versatile building block in organic synthesis. Its unique pyrazolopyridine scaffold is engineered for the development of novel bioactive compounds, offering significant value in medicinal chemistry research. This compound is primarily targeted for use by pharmaceutical R&D teams and fine chemical manufacturers engaged in creating next-generation therapeutics.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of active pharmaceutical ingredients (APIs) targeting various therapeutic areas.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and the development of novel drug candidates.
• Organic Synthesis Building Block: Employed in complex multi-step syntheses to construct more elaborate heterocyclic systems.
• Agrochemical Development: Potential application as an intermediate in the research and synthesis of new crop protection agents.
• Material Science Research: Investigated for the creation of specialty chemicals and functional materials with specific electronic or binding properties.

Basic Information

Product Name	6-Cyclopropyl-1-Ethyl-1H-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid
CAS No.	954261-91-7
Molecular Formula	C₁₂H₁₃N₃O₂
Molecular Weight	231.25 g/mol
Synonyms	6-Cyclopropyl-1-ethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid; 1-Ethyl-6-cyclopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid; 4-Pyrazolo[3,4-b]pyridinecarboxylic acid, 6-cyclopropyl-1-ethyl-1H-; 954261-91-7; 6-Cyclopropyl-1-ethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate (deprotonated form); Pyrazolopyridine-4-carboxylic acid derivative; 1-Ethyl-6-cyclopropyl-4-carboxypyrazolo[3,4-b]pyridine
EINECS	Contact for details

Quality Control

Our production of 6-Cyclopropyl-1-Ethyl-1H-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid adheres to stringent quality management protocols. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific client requirements. We operate under a cGMP-compliant mindset suitable for pharmaceutical intermediate applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be moisture-sensitive; keep the container tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials such as strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.